Back to Search Start Over

COVID-19 Vaccination Coverage, and Rates of SARS-CoV-2 Infection and COVID-19–Associated Hospitalization Among Residents in Nursing Homes — National Healthcare Safety Network, United States, October 2023–February 2024.

Authors :
Franklin, David
Barbre, Kira
Rowe, Theresa A.
Reses, Hannah E.
Massey, Jason
Lu Meng
Dollard, Philip
Dubendris, Heather
Stillions, Molly
Robinson, Lindsay
Clerville, Jacques W.
Slifka, Kara Jacobs
Benin, Andrea
Bell, Jeneita M.
Source :
MMWR: Morbidity & Mortality Weekly Report. 4/18/2024, Vol. 73 Issue 15, p339-344. 6p.
Publication Year :
2024

Abstract

Nursing home residents are at increased risk for developing severe COVID-19. Nursing homes report weekly facilitylevel data on SARS-CoV-2 infections, COVID-19–associated hospitalizations, and COVID-19 vaccination coverage among residents to CDC’s National Healthcare Safety Network. This analysis describes rates of incident SARS-CoV-2 infection, rates of incident COVID-19–associated hospitalization, and COVID-19 vaccination coverage during October 16, 2023– February 11, 2024. Weekly rates of SARS-CoV-2 infection ranged from 61.4 to 133.8 per 10,000 nursing home residents. The weekly percentage of facilities reporting one or more incident SARS-CoV-2 infections ranged from 14.9% to 26.1%. Weekly rates of COVID-19–associated hospitalization ranged from 3.8 to 7.1 per 10,000 residents, and the weekly percentage of facilities reporting one or more COVID-19–associated hospitalizations ranged from 2.6% to 4.7%. By February 11, 2024, 40.5% of nursing home residents had received a dose of the updated 2023–2024 COVID-19 vaccine that was first recommended in September 2023. Although the peak rate of SARS-CoV-2 infection among nursing home residents was lower during the 2023–24 respiratory virus season than during the three previous respiratory virus seasons, nursing home residents continued to be disproportionately affected by SARS-CoV-2 infection and related severe outcomes. Vaccination coverage remains suboptimal in this population. Ongoing surveillance for SARS-CoV-2 infections and COVID-19–associated hospitalizations in this population is necessary to develop and evaluate evidence-based interventions for protecting nursing home residents. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
01492195
Volume :
73
Issue :
15
Database :
Academic Search Index
Journal :
MMWR: Morbidity & Mortality Weekly Report
Publication Type :
Academic Journal
Accession number :
176710363
Full Text :
https://doi.org/10.15585/mmwr.mm7315a3